Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
Hemant K Sharma, Managing Director and Anantaa GSK Innovation Pvt. Ltd., shared a post on LinkedIn:
“Japan’s Universal Artificial Blood Research: A Potential Breakthrough in Transfusion Medicine
Imagine a future where blood shortages could be less challenging and emergency transfusions could become more accessible.
Researchers at Nara Medical University, Japan, have been developing haemoglobin-based artificial blood using haemoglobin vesicles. This technology is being investigated for its potential to work across different blood types and offer longer storage than conventional donated blood.
Why this research matters:
- Potential to support patients when compatible donor blood is difficult to obtain.
- Could improve emergency preparedness and blood supply logistics.
- May offer new possibilities for storing and transporting blood substitutes.
Important: This technology remains under research and clinical evaluation. It is not yet a routine replacement for donated blood, and its safety and effectiveness must be established through further trials.
Scientific progress is most meaningful when it brings us closer to saving lives.
Source: Nara Medical University research; NDTV Science coverage.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026
-
Oct 10, 2026, 17:28Juan José López Núñez: Bringing Patients and Families Together for World Thrombosis Day
-
Oct 10, 2026, 16:11David C. Madoff: HCC With Portal Vein Tumor Thrombosis East vs West
-
Oct 10, 2026, 15:50M Velia Antonini: ECMO Cannula Design and Its Impact on Blood Flow, Thrombosis and Hemolysis
-
Oct 10, 2026, 15:14Cihan Ay: PhD With Distinction in Thrombosis Research in Patients With Primary Brain Tumors
-
Oct 10, 2026, 15:07Khalid Ahmed: Mortality and Survival in Young People With Sickle Cell Disease and Beta Thalassaemia in England 1997 to 2025